COMMUNIQUÉS West-GlobeNewswire

Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2018 Financial Results Conference Call and Webcast
08/02/2019
CAMBRIDGE, Mass., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Delcath Announces Acceptance of Abstract for Oral Presentation at ECIO 2019
08/02/2019
NEW YORK, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces an abstract from a [...]
Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
08/02/2019
Results from the study demonstrate that subcutaneous MarzAA (FVIIa) significantly reduces both annualized bleed rate and the percentage of days with bleeding Enrollment in the Phase 2 portion of the trial is complete [...]
Tabula Rasa HealthCare to Present at HIMSS19
08/02/2019
TRHC to debut state-of-the-art SMART on FHIR integration to expand access to its proven Medication Risk Mitigation technology in the U.S. and globally MOORESTOWN, N.J., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa [...]
R1 Develops Technology and Innovation Center in Collaboration with Intermountain Healthcare
08/02/2019
State-of-the-art development, training and education facility to foster RCM innovation to drive financial results for healthcare providers and improve the patient experience CHICAGO, Feb. 08, 2019 (GLOBE NEWSWIRE) -- R1 [...]
Acasti Pharma Schedules Third Quarter Fiscal 2019 Conference Call
08/02/2019
LAVAL, Quebec, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Helix BioPharma Corp. Board Changes
08/02/2019
RICHMOND HILL, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Myriad to Present New Data for Its Expanded Carrier and Noninvasive Prenatal Screens at the 2019 Society for Maternal-Fetal Medicine Annual Meeting
08/02/2019
SALT LAKE CITY, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and personalized medicine, today announced that its Myriad Women’s Health business unit [...]
Summit Therapeutics to Present at the BIO CEO & Investor Conference
08/02/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Present at the BIO CEO & Investor Conference Oxford, UK, and Cambridge, MA, US, 8 February 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM [...]
ReWalk Robotics Reports Fourth Quarter 2018 Financial Results
08/02/2019
— 2018 total revenue of $6.5 million and $1.6 million during the fourth quarter of 2018 — — Preparing for 2019 commercial launch of ReStore for stroke patients — YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Feb. 08, [...]
Emerald Health Therapeutics Announces Pure Sunfarms’ Selection to Supply Ontario Cannabis Store
08/02/2019
Pure Sunfarms Ontario supply agreement adds to Emerald’s existing supply agreement with the Ontario Cannabis Store VICTORIA, British Columbia, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (" [...]
Covetrus Celebrates Launch as Newly Formed Public Company
08/02/2019
A global leader in the animal health industry begins trading on Nasdaq Stock Market PORTLAND, Maine, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Today, Covetrus (NASDAQ:CVET) celebrates the combination of two unique and [...]
Invitation: Terveystalo Plc full-year 2018 result - Webcast and conference call on 14 February 2019
08/02/2019
Terveystalo Plc will publish its full-year 2018 result on 14 February at 9:00 EET. (Finnish time). The report and related materials will be available on https://www.terveystalo.com/en/investors/Financial-information/ [...]
Chi-Med to Announce 2018 Final Results
08/02/2019
LONDON, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) will announce its final results for the year ended December 31, 2018 on Monday, March 11, 2019 at 7:00 am [...]
C-RAD AB – Consolidated Year-End report January-December 2018
08/02/2019
STRONG FOURTH QUARTER RESULTS IN FULL YEAR PROFIT Key events in the period January - December 2018 FOURTH QUARTER 2018 Order intake: 75.6 (47.5) MSEK, +59%. Revenues: 57.7 (42.0) MSEK, +37%. Operating profit: 3.3 (1.1) [...]
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2018
08/02/2019
Message from the CEO IBT reached several significant milestones during 2018. IBT reached agreement with a CRO (Contract Research Organization) to conduct the pivotal Phase III clinical trial, The Connection Study, and [...]
Strong European Cresemba® (isavuconazole) sales trigger USD 5 million milestone payment to Basilea from Pfizer
08/02/2019
Basel, Switzerland, February 08, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the European sales of the antifungal Cresemba ® (isavuconazole) by Pfizer exceeded the threshold triggering the first [...]
Pixium Vision annonce ses résultats annuels 2018 et fait le point sur ses activités
08/02/2019
PRIMA, des performances cliniques supérieures aux attentes initiales dans la DMLA sèche Résultats de l’étude de faisabilité positifs, supports à la préparation de l’étude pivot européenne, prochaine étape vers l’accès [...]
Pixium Vision announces its 2018 annual results and provides business update
08/02/2019
PRIMA clinical performance exceeded initial expectations in advanced dry-AMD; Positive feasibility study results to enable the European pivotal trial, the next step to market for PRIMA; Significant reduction in 2018 [...]

Pages